Login to Your Account

Pharma: Other News To Note

Tuesday, July 24, 2012
• Sandoz Inc., a unit of Basel, Switzerland-based Novartis AG, said it completed its $1.525 billion acquisition of specialty U.S. dermatology company Fougera Pharmaceuticals Inc..

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription